These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2080156)

  • 1. [Effectiveness of the treatment of patients with pulmonary tuberculosis using a liver protector zixoryn].
    Mezhebovskiĭ VR
    Probl Tuberk; 1990; (10):32-5. PubMed ID: 2080156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined chemotherapy of toxic hepatitis in patients with pulmonary tuberculosis].
    Frolov VM; Peresadin NA; Pustovoĭ IuG
    Probl Tuberk; 1992; (5-6):30-1. PubMed ID: 1409510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of the treatment of patients with pulmonary tuberculosis by the short-term chemotherapy method with reference to the side effects of the drugs].
    Westfal I; Spychalski W; Szelerska-Twardosz H; Grzegorzewska A; Ryszewski W
    Pneumonol Pol; 1988 Apr; 56(4):163-5. PubMed ID: 3412967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VA; Sokolova GB; Ziia AV; Zeliger LR; Ivleva AIa
    Ter Arkh; 1987; 59(7):75-7. PubMed ID: 3672366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxic-allergic and viral hepatitis in patients with pulmonary tuberculosis].
    Cherednichenko LP; Bessonova GS; Mikhaĭlova ES
    Probl Tuberk; 1989; (12):38-41. PubMed ID: 2628975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver changes during treatment with antitubercular agents].
    Velojic D; Jankovic Z; MArsenic B
    Plucne Bolesti Tuberk; 1975; 27(1-2):53-60. PubMed ID: 1161927
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reamberin in tuberculosis chemotherapy and its effect on liver function].
    Antibiot Khimioter; 2013; 58(3-4):33-6. PubMed ID: 24640150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood tuberculosis: consensus statement of IAP Working Group.
    Amdekar YK
    Indian Pediatr; 1998 Dec; 35(12):1263-4. PubMed ID: 10216716
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a mathematic method of prognosis in adverse reactions to chemotherapy of tuberculosis].
    Kazakov KS; Kozarev MI
    Probl Tuberk; 1987; (2):43-5. PubMed ID: 3575279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of newly detected destructive pulmonary tuberculosis in patients with pathology of the gastrointestinal tract and liver].
    Potashova VA; Zhukova EM; Borovinskaia TA; Fomintseva OA; Fedorova MV
    Probl Tuberk; 1990; (7):65-6. PubMed ID: 2235957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs].
    Mishin VIu; Vasil'eva IA; Makieva VG; Kuz'mina NV; Prikazchikova AV; Khoroshutina VV
    Probl Tuberk Bolezn Legk; 2003; (7):24-9. PubMed ID: 12939872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are antitubercular drugs prescribed correctly and scientifically?
    Sahoo RC
    J Assoc Physicians India; 1994 Apr; 42(4):349-50. PubMed ID: 7860579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients].
    Sukhanov DS; Okovityĭ SV; Demidik SN; Ivanov AK; Romantsov MG
    Eksp Klin Farmakol; 2012; 75(6):40-3. PubMed ID: 22891441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.